Poseida Therapeutics (NASDAQ:PSTX) is expected to release results from the phase 1 study using P-BCMA-ALLO1 for the treatment of patients with relapsed or refractory
In the face of impending Federal Reserve rate cuts, investors may want to consider extending duration from Treasury bills to short-term bonds. Surprisingly, the
Check out the companies making headlines in after-hours trading. Adobe — The software stock tumbled 10% on the back of weak guidance for current-quarter